Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Akebia Therapeutics (AKBA) Asset Utilization Ratio (2017 - 2025)

Akebia Therapeutics (AKBA) has disclosed Asset Utilization Ratio for 9 consecutive years, with 0.64 as the latest value for Q4 2025.

  • Quarterly Asset Utilization Ratio fell 14.83% to 0.64 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.64 through Dec 2025, down 14.83% year-over-year, with the annual reading at 0.79 for FY2025, 14.16% up from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.64 at Akebia Therapeutics, up from 0.63 in the prior quarter.
  • The five-year high for Asset Utilization Ratio was 0.75 in Q4 2024, with the low at 0.17 in Q2 2022.
  • Average Asset Utilization Ratio over 5 years is 0.45, with a median of 0.53 recorded in 2024.
  • The sharpest move saw Asset Utilization Ratio crashed 39.36% in 2022, then soared 223.38% in 2023.
  • Over 5 years, Asset Utilization Ratio stood at 0.27 in 2021, then dropped by 14.75% to 0.23 in 2022, then surged by 148.4% to 0.58 in 2023, then increased by 28.94% to 0.75 in 2024, then dropped by 14.83% to 0.64 in 2025.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.64, 0.63, and 0.62 for Q4 2025, Q3 2025, and Q2 2025 respectively.